Lilly Deutschland GmbH Germany
Lilly Deutschland GmbH Germany
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IMPLEMENTING PATIENTS' COMPETENCE IN ORAL EBC THERAPY PERSISTENCE | HR+/HER2- Early Breast Cancer | Not yet recruiting | Not applicable | 2026-09-10 | NCT07521202 | |
| Patient Relevant Outcomes Improvement Program in High Risk Hormone Receptor Positive (HR+) Breast Cancer | HR+/HER2- Early Breast Cancer | Recruiting | Not stated | 2026-05-14 | NCT07531693 | |
| German Dementia Registry | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, Nerve Degeneration, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Not stated | 2026-02-25 | NCT07433010 |